Page last updated: 2024-10-31

neostigmine and Coronary Vessel Anomalies

neostigmine has been researched along with Coronary Vessel Anomalies in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Coronary Vessel Anomalies: Malformations of CORONARY VESSELS, either arteries or veins. Included are anomalous origins of coronary arteries; ARTERIOVENOUS FISTULA; CORONARY ANEURYSM; MYOCARDIAL BRIDGING; and others.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
James, TN1

Other Studies

1 other study available for neostigmine and Coronary Vessel Anomalies

ArticleYear
Small arteries of the heart.
    Circulation, 1977, Volume: 56, Issue:1

    Topics: Acetylcholine; Amyloidosis; Animals; Arterial Occlusive Diseases; Arteries; Cardiomegaly; Coronary V

1977